Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits

International Journal of Pharmaceutics

Volumn 253, Issue 1-2, 2003, Pages 121-132

  Awasthi, V D ^a   Garcia, D ^a   Goins, B A ^a   Phillips, W T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Liposome encapsulated hemoglobin; Liposomes; Technetium 99m

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; DISTEAROYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; MACROGOL; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTOPSY; CIRCULATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; ISOTOPE LABELING; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; RADIOACTIVITY; SCINTILLATION CAMERA; SPLEEN;

EID: 0037422368     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00703-2     Document Type: Article

References (53)

1. Abra R.M., Hunt C.A. Liposome disposition in vivo. IV. The interaction of sequential doses of liposomes having different diameters. Res. Commun. Chem. Pathol. Pharmacol. 36:1982;17-31.
2. Ahl P.L., Bhatia S.K., Meers P., Roberts P., Stevens R., Dause R., Perkins W.R., Janoff A.S. Enhancement of the in vivo circulation lifetime of L-a-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization. Biochim. Biophys. Acta. 1329:1997;370-382.
3. Allen T., Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta. 1068:1991;122-141.
4. Allen T.M., Hansen C., Rutledge J. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta. 981:1989;27-35.
5. Allen T.M., Hansen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivative of poly(ethylene) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta. 1066:1991;29-36.
6. Awasthi V.D., Goins B., Klipper R., Loredo R., Korvick D., Phillips W.T. Comparison of dual radiolabeled liposomes (DRL), Tc-99m-MDP and Ga-67 citrate for imaging osteomyelitis in rabbit model. J. Nucl. Med. 38:1997;182P.
7. Awasthi V., Goins B., Klipper R., Loredo R., Korvick D., Phillips W.T. Imaging experimental osteomyelitis using radiolabeled liposomes. J. Nucl. Med. 39:1998;1089-1094.
8. Boerman O.C., Oyen W.J.G., van Bloois L., Koenders E.B., van der Meer J.W.M., Corstens F.H.M., Storm G. Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. J. Nucl. Med. 38:1997;489-493.
9. Bradley A.J., Devine D.V., Ansell S.M., Janzen J., Brooks D.E. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch. Biochem. Biophys. 357:1998;185-194.
10. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51:1999;691-743.
11. Espinola L.G., Beaucaire J., Gottschalk A., Caride V.J. Radiolabeled liposomes as metabolic and scanning tracers in mice. II. In-111 oxine compared with Tc-99m DTPA, entrapped in multilamellar lipid vesicles. J. Nucl. Med. 20:1979;434-440.
12. Frank, D.W., 1976. Physiological data of laboratory animals. In: Melby Jr., E.C. (Ed.), Handbook of Laboratory Animal Science, vol. 3. CRC Press, Boca Raton, FL, pp. 23-64.
13. Fujii, G., 1996. Liposomal amphotericin B (AmBisome): realization of the drug delivery concept. In: Rosoff, M. (Ed.), Vesicles. Marcel Dekker, New York, pp. 491-520.
14. Gabizon A., Papahadjoulos D. The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim. Biophys. Acta. 1103:1992;94-100.
15. Goins B.A., Phillips W.T. The use of scintigraphic imaging as a tool in the development of liposome formulations. Prog. Lipid Res. 40:2001;95-123.
16. Goins B.A., Klipper R., Rudolph A.S., Phillips W.T. Use of technetium-99m-liposomes in tumor imaging. J. Nucl. Med. 35:1994;1491-1498.
17. Goins B.A., Klipper R., Sanders J., Cliff R.O., Rudolph A.S., Phillips W.T. Physiological responses, organ distribution, and circulation kinetics in anesthetized rats after hypovolemic exchange transfusion with technetium-99m-labeled liposome-encapsulated hemoglobin. Shock. 4:1995;121-130.
18. Gregoriadis, G., 1995. Fate of liposomes in vivo and its control: a historical perspective. In: Lasic, D.D., Martin, F. (Eds.), Stealth Liposomes. CRC Press, Boca Raton, FL, pp. 7-12.
19. Harashima H., Sakata K., Funato K., Kiwada H. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm. Res. 11:1994;402-406.
20. Johnstone S.A., Masin D., Mayer L., Bally M.B. Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages. Biochim. Biophys. Acta. 1513:2001;25-37.
21. Klibanov A.L., Maruyama K., Bekerleg A.M., Torchilin V.P., Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta. 1062:1991;142-148.
22. Lasic, D.D., 1996. Liposomes in drug delivery. In: Rosoff, M. (Ed.), Vesicles. Marcel Dekker, New York, pp. 447-476.
23. Lasic, D.D., Martin, F. (Eds.), 1995. Stealth Liposomes. CRC Press, Boca Raton, FL.
24. 99mTc by the hydrazino nicotinyl derivative J. Nucl. Med. 40:1999;192-197.
25. Laverman P., Brouwers A.H., Dams E.T.M., Oyen W.J.G., Storm G., Rooijen N.V., Corstens F.H.M., Boerman O.C. Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J. Pharmacol. Exp. Ther. 293:2000;996-1001.
26. Litzinger D.C., Huang L. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen. Biochim. Biophys. Acta. 1127:1992;249-254.
27. Litzinger D.C., Buiting A.M.J., van Rooijen N., Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta. 1190:1994;99-107.
28. Liu D., Mori A., Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim. Biophys. Acta. 1104:1992;95-101.
29. Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta. 1128:1992;44-49.
30. Mayer L.D., Tai L.C.L., Ko D.S.C., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 49:1989;5922-5930.
31. Morgan J.R., Williams L.A., Howard C.B. Technetium-labelled liposome imaging for deep-seated infection. Br. J. Radiol. 58:1985;35-39.
32. Nagayasu A., Uchiyama K., Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Deliv. Rev. 40:1999;75-87.
33. Oussoren C., Zuidema J., Crommelin D.J.A., Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochim. Biophys. Acta. 1328:1997;261-272.
34. Oyen W.J.G., Boerman O.C., Storm G., Bloois L.V., Koenders E.B., Crommelin D.J.A., Meer J.W.M.V.D., Corstens F.H.M. Labelled stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy? Nucl. Med. Comm. 17:1996;742-748.
35. Perkins W.R., Minchey S.R., Ahl P.L., Janoff A.S. The determination of liposome captured volume. Chem. Phys. Lipids. 64:1993;197-217.
36. Petty, C., 1982. Research Techniques in the Rats. Charles C. Thomas, Springfield, IL.
37. Phillips W.T. Delivery of gamma-imaging agents by liposomes. Adv. Drug Deliv. Rev. 37:1999;13-32.
38. Phillips, W., Goins, B., 1995. Targeted delivery of imaging agents by liposomes. In: Torchilin, V.P. (Ed.), Handbook of Targeted Delivery of Imaging Agents. CRC Press, Boca Raton, FL, pp. 149-173.
39. Phillips W.T., Rudolph A.S., Goins B., Timmons J.H., Klipper R., Blumhardt R. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl. Med. Biol. 19:1992;539-547.
40. Phillips W., Klipper R., Awasthi V., Rudolph A., Cliff R., Kwasiborski V., Goins B. Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. J. Pharmacol. Exp. Ther. 288:1999;665-670.
41. Rudolph A.S., Klipper R.W., Goins B., Phillips W.T. In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10976-10980.
42. Senior J., Delgado C., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta. 1062:1991;77-82.
43. Stewart J.C.M. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 104:1980;10-14.
44. Szebeni J. The interaction of liposomes with the complement system. Crit. Rev. Ther. Drug Carrier Syst. 15:1998;57-88.
45. Szebeni J., Alving C.R. Complement-mediated acute effects of liposome-encapsulated hemoglobin. Artif. Cells Blood Substit. Immobil. Biotechnol. 27:1999;23-41.
46. Szebeni J., Fontana J.L., Wassef N.M., Mongan P.D., Morse D.S., Dobbins D.E., Stahl G.L., Bunger R., Alving C.R. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation. 99:1999;2302-2309.
47. Szebeni J., Baranyi L., Savay S., Bodo M., Morse D.S., Basta M., Stahl G.L., Bunger R., Alving C.R. Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am. J. Physiol. 279:2000;H1319-H1328.
48. Torchilin V.P. Liposomes as delivery agents for medical imaging. Mol. Med. Today. 2:1996;242-249.
49. Torchilin V.P., Papisov M.I. Why do polyethylene glycol-coated liposomes circulate so long? J. Liposome Res. 4:1994;725-739.
50. Tsuchida, E., 1995. Artificial Red Cells: Materials, Performances and Clinical Study as Blood Substitutes. Wiley, Chichester, UK.
51. Woodle M.C., Collins L.R., Sponsler E., Kossovsky N., Papahadjoulos D., Martin F.J. Sterically stabilized liposomes: reduction in electrophoretic mobility but not electrostatic surface potential. Biophys. J. 61:1992;902-910.
52. Woodle, M.C., S.N.M., Working, P.K., 1995. Biological properties of sterically stabilized liposomes. In: Lasic, D.D., Martin, F. (Eds.), Stealth Liposomes. CRC Press, Boca Raton, FL, pp. 103-117.
53. Zou Y., Ling Y.-H., Reddy S., Priebe W., Perez-Solerr R. Effect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes. Int. J. Cancer. 61:1995;666-671.